- Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Praxis Precision Medicines Inc Epilepsy Day Transcript
Good morning, and welcome, everyone. Thanks for being here in New York City with us and in the webcast. It's a really -- real honor and a privilege to have all of you here for our second Analyst Day, our Epilepsy Day today. As you can guess, we're going to be making some forward-looking statements. I'm not going to be reading out the text here, but I do encourage every and each one of you to look into our SEC filings, especially our Form 10-K filed with EDGAR.
So why are we here today, right? We're going to be talking mostly about the epilepsy franchise, but it would be disingenuous not to talk about the other 2 franchise, like each one of them have significant value creation for patients, first and foremost, it should starts and ends with who we are serving as a company, as a community, as investors.
The second is there's a number of real big events for Praxis coming up. And that was the disingenuous part, I'm just not addressing that upfront. I'm incredibly excited and all the team at Praxis and everyone
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)